Examining NVLX as an mmj candidate that hasn't participated...?

 

 

From: Greenbackers

Sent: Thursday, January 9, 2014 10:51 AM

To: Undisclosed-Recipient:;

Subject: Examining NVLX as an mmj candidate that hasn't participated...?

 

Focus:

 

While most mmjs are up 3/4 hundred percent as evidenced by the likes of frequent mention CBIS,

 

 

CBIS

12:27pm EST

0.1592

+0.0407

+34.35%

101,700,889

2,176,910

 

Although not a mmj pure play, might be time to take a look at NVLX which hasn't taken off, but is displaying signs it might...?....Definitely seeing signs of a pickup....

 

Nuvilex, Inc. (NVLX)

-Other OTC

0.14 0.01(8.16%) 12:28PM EST

Prev Close:	0.13
Open:	0.14
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A
Beta:	N/A
Next Earnings Date:	N/A

Day's Range:	0.14 - 0.16
52wk Range:	0.03 - 0.22
Volume:	6,998,348
Avg Vol (3m):	1,655,980
Market Cap:	85.69M
P/E (ttm):	N/A
EPS (ttm):	-0.02
Div & Yield:	N/A (N/A)

 

Headlines

• Nuvilex Growing Medical Marijuana Sciences to Lead Marijuana Research IndustryMarketwired(Thu 9:30AM EST)
• Nuvilex's Medical Marijuana Sciences Ready to Welcome New York State's Approval of the DrugMarketwired(Tue, Jan 7)
• Nuvilex, Inc. Subsidiary Medical Marijuana Sciences, Inc. Appoints University of Northern Colorado Professor, Richard M. Hyslop, Ph.D., to Scientific Advisory BoardGlobeNewswire(Mon, Jan 6)
• Nuvilex's Medical Marijuana Subsidiary Poised for Growth in the New YearMarketwired(Fri, Jan 3)
• Dr. Mark L. Rabe Develops Charter for Scientific Advisory Board of Nuvilex's Subsidiary, Medical Marijuana Sciences, Inc.GlobeNewswire(Mon, Dec 30)
• Nuvilex Lands Leading Figure in Medical Marijuana Field as Chairman of Subsidiary's Scientific Advisory BoardMarketwired(Mon, Dec 23)
• NUVILEX, INC. FinancialsEDGAR Online Financials(Sat, Dec 21)
• Nuvilex Readies for Late-Stage Trials as NCI Seeks New Pancreatic Cancer DrugsAccesswire(Fri, Dec 20)
• Nuvilex's Provides Progress Update on Cell Cloning Being Performed by Inno BiologicsGlobeNewswire(Thu, Dec 19)
• Nuvilex's Medical Marijuana Research Could Use Cell Encapsulation Technology to Address Brain CancersMarketwired(Wed, Dec 18)
• Nuvilex to Answer Increasing Calls for Better Pancreatic Cancer Treatment Without GemcitabineMarketwired(Mon, Dec 16)
• NUVILEX, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Dec 16)
• Nuvilex's Preparations for Planned Late-Phase Clinical Trials Timely in Light of Increasing Incidence of Pancreatic CancerGlobeNewswire(Thu, Dec 12)
• Nuvilex's Contractor, Inno Biologics, Employs Clone-Pix(TM) Technology in Cloning Cells for Future Clinical TrialsGlobeNewswire(Wed, Dec 11)
• Newly Transformed Nuvilex To Enjoy Strong 2014at Seeking Alpha(Tue, Dec 10)

» More Headlines for NVLX

Add NVLX Headlines to My Yahoo!

+ My Yahoo! RSS

Press Releases

• Nuvilex Growing Medical Marijuana Sciences to Lead Marijuana Research IndustryMarketwired(Thu 9:30AM EST)
• Nuvilex's Medical Marijuana Sciences Ready to Welcome New York State's Approval of the DrugMarketwired(Tue, Jan 7)
• Nuvilex, Inc. Subsidiary Medical Marijuana Sciences, Inc. Appoints University of Northern Colorado Professor, Richard M. Hyslop, Ph.D., to Scientific Advisory BoardGlobeNewswire(Mon, Jan 6)

» More Press Releases for NVLX

Reports

• ValuEngine Industry Report for Chemicals-specialtyValuEngine, Inc.(Jan 9)

» More Reports for NVLX